Related Experiment Video
Updated: Mar 25, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways
Ming-Yi Xu1, Rong Chen1, Jing-Xia Yu1
1Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
Abstract:
Zinc-α2-glycoprotein 1 (AZGP1) has been found to play important roles in TGF-β1 induced epithelial-to-mesenchymal transition (EMT). However, the mechanisms of AZGP1 inhibiting EMT and its therapeutic potential remain unknown in hepatocellular carcinoma (HCC). AZGP1, TGF-β1 or ERK2 expressions were examined in liver tissues of HCC patients and rat model. The effect of AZGP1 on EMT and crosstalking of TGFβ1-ERK2 signaling in human hepatic cancer cell was tested in vitro and in vivo. Hepatic expression of AZGP1 was nearly deficient in HCC patients and rats. It was proved that AZGP1 has the ability of down-regulating mesenchymal markers, up-regulating epithelial marker, inhibiting cell invasion and suppressing EMT in human HCC cells. The results clarified that AZGP1 has the effect on blocking TGF-β1 mediated ERK2 phosphorylation leading to depressing EMT and invasive potential in vitro. Local injection of AZGP1 mimic in vivo could significantly withhold lung metastasis in HCC. In conclusion, loss of AZGP1 could trigger EMT induced by TGFβ1-ERK2 signaling, confuse in energy metabolism, reduce cell proliferation and apoptosis, activate survival signals and promote invasion. Up-regulation of AZGP1 should be proposed to reverse EMT and might be a new promising therapy for HCC.
Insights
Loss of Zinc-α2-glycoprotein 1 (AZGP1) promotes hepatocellular carcinoma (HCC) invasion by activating TGF-β1-ERK2 signaling. Restoring AZGP1 expression could reverse this process, offering a potential new therapy for HCC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Zinc-α2-glycoprotein 1 (AZGP1) is implicated in TGF-β1-induced epithelial-to-mesenchymal transition (EMT).
- Mechanisms of AZGP1's role in inhibiting EMT and its therapeutic potential in hepatocellular carcinoma (HCC) are not fully understood.
Purpose of the Study:
- To investigate the role of AZGP1 in inhibiting EMT in HCC.
- To elucidate the mechanisms underlying AZGP1's function in HCC.
- To evaluate the therapeutic potential of AZGP1 in HCC.
Main Methods:
- Examined AZGP1, TGF-β1, and ERK2 expression in HCC patient liver tissues and a rat model.
- Tested AZGP1's effect on EMT and TGFβ1-ERK2 signaling in human hepatic cancer cells in vitro and in vivo.
- Administered local AZGP1 mimic injections in a HCC rat model.
Main Results:
- Hepatic AZGP1 expression was significantly reduced in HCC patients and rats.
- AZGP1 suppressed EMT by down-regulating mesenchymal markers and up-regulating epithelial markers.
- AZGP1 blocked TGF-β1-mediated ERK2 phosphorylation, inhibiting cell invasion and EMT in vitro.
- In vivo AZGP1 mimic injection significantly reduced lung metastasis in HCC.
Conclusions:
- Loss of AZGP1 facilitates EMT via TGF-β1-ERK2 signaling, promoting HCC invasion.
- AZGP1 upregulation can reverse EMT and holds promise as a novel therapeutic strategy for HCC.
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
GPCRs Regulate Adenylyl Cylase Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

